Direct medical cost of type 2 diabetes in Singapore

Charmaine Shuyu Ng, Matthias Paul Han Sim Toh, Yu Ko, Joyce Yu Chia Lee

Research output: Contribution to journalArticle

17 Citations (Scopus)

Abstract

Due to the chronic nature of diabetes along with their complications, they have been recognised as a major health issue, which results in significant economic burden. This study aims to estimate the direct medical cost associated with type 2 diabetes mellitus (T2DM) in Singapore in 2010 and to examine both the relationship between demographic and clinical state variables with the total estimated expenditure. The National Healthcare Group (NHG) Chronic Disease Management System (CDMS) database was used to identify patients with T2DM in the year 2010. DM-attributable costs estimated included hospitalisations, accident and emergency (A&E) room visits, outpatient physician visits, medications, laboratory tests and allied health services. All charges and unit costs were provided by the NHG. A total of 500 patients with DM were identified for the analyses. The mean annual direct medical cost was found to be $2,034, of which 61% was accounted for by inpatient services, 35% by outpatient services, and 4% by A&E services. Independent determinants of total costs were DM treatments such as the use of insulin only (p

Original languageEnglish
Article numbere0122795
JournalPLoS One
Volume10
Issue number3
DOIs
Publication statusPublished - Mar 27 2015

ASJC Scopus subject areas

  • Agricultural and Biological Sciences(all)
  • Biochemistry, Genetics and Molecular Biology(all)
  • Medicine(all)

Fingerprint Dive into the research topics of 'Direct medical cost of type 2 diabetes in Singapore'. Together they form a unique fingerprint.

  • Cite this

    Ng, C. S., Toh, M. P. H. S., Ko, Y., & Lee, J. Y. C. (2015). Direct medical cost of type 2 diabetes in Singapore. PLoS One, 10(3), [e0122795]. https://doi.org/10.1371/journal.pone.0122795